Miriam Alb
Wuerzburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humans.
Journal: Frontiers in pharmacology
Published: March 25, 2026
Perspective of using in vitro models to understand immunotherapy-induced cytokine release syndrome.
Journal: Frontiers in immunology
Published: October 25, 2025
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy.
Journal: Blood cancer discovery
Published: July 31, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.
Journal: Frontiers in immunology
Published: March 28, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 27, 2025
Short-Chain Fatty Acids Modulate Anti-ROR1 CAR T-Cell Function and Exhaustion in an Intestinal Adenocarcinoma-on-Chip Model.
Journal: Advanced healthcare materials
Published: December 12, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assay.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Cellular Therapies for Multiple Myeloma: Engineering Hope.
Journal: Cancers
Published: October 15, 2024
Last Updated: 09/26/2026